Showing results (41-50 of 1,042) with videos related to
Sort By:
Pageof 105
Advances in Radiation Oncology|January 18, 2021
A National Survey of Radiation Oncology Experiences Completing Tele-Consultations During the Coronavirus Disease (COVID-19) PandemicArpit M Chhabra, Mudit Chowdhary, J Isabelle Choi, et al.Cancers|October 26, 2024
Proton Therapy in Uveal MelanomaAdrian Wai Chan, Haibo Lin, Irini Yacoub, et al.Annals of Surgical Oncology|May 4, 2018
Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of SurvivalVivek Verma, Richard L Sleightholm, Chad G Rusthoven, et al.Journal for Immunotherapy of Cancer|November 25, 2018
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitorsVivek Verma, Tanja Sprave, Waqar Haque, et al.Seminars in Thoracic and Cardiovascular Surgery|June 22, 2019
Management of Clinically Lymph Node-Positive Malignant Pleural MesotheliomaVivek Verma, Rodney E Wegner, Sebastian Adeberg, et al.Advances in Radiation Oncology|April 7, 2022
Phantosmia Among Pediatric, Adolescent, and Young Adult Patients Receiving Proton Beam TherapyShoshana J Rosenzweig, Stanislav Lazarev, Shaakir Hasan, et al.Journal of Gastrointestinal Oncology|October 12, 2019
Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalationShaakir Hasan, Stephen Abel, Vivek Verma, et al.The Journal of Thoracic and Cardiovascular Surgery|November 21, 2018
Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resectionVivek Verma, Christopher A Ahern, Christopher G Berlind, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 2024
A Novel Dose Rate Optimization Method to Maximize Ultrahigh-Dose-Rate Coverage of Critical Organs at Risk Without Compromising Dosimetry Metrics in Proton Pencil Beam Scanning FLASH Radiation TherapyXingyi Zhao, Sheng Huang, Haibo Lin, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 11, 2019
Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United StatesVivek Verma, Waqar Haque, Taylor R Cushman, et al.Pageof 105